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Abstract
Background Flat pigmented facial lesions are difﬁcult to diagnose even with dermatoscopy. It is controversial how
additional information obtained by in vivo reﬂectance confocal microscopy (RCM) impacts the diagnosis and
management.
Objective To examine what in vivo reﬂectance confocal microscopy of ﬂat pigmented facial lesions adds to clinical
examination using dermatoscopy including digital dermatoscopic monitoring.
Methods We prospectively collected 70 cases of ﬂat pigmented facial lesions and recorded diagnoses and manage-
ment decisions by experts based on direct clinical examination aided by dermatoscopy including digital dermatoscopic
monitoring and by remote experts who reviewed the corresponding confocal images. The expert confocal readers were
blinded to the clinical and dermatoscopic appearance of the lesion.
Results The sensitivity of dermatoscopy plus digital dermatoscopic monitoring was 95.0% (95% CI 75.13% to
99.87%) and the speciﬁcity was 84.0% (95% CI 70.89% to 92.83%). The sensitivity of RCM was 95.0% (95% CI
75.13% to 99.87%) and the speciﬁcity was 82.0% (95% CI 68.56% to 91.42%).
Conclusion Although most ﬂat pigmented facial lesions can be managed by clinical examination and dermatoscopy
alone, confocal microscopy is a useful adjunct in selected lesions. If RCM is not correlated with clinical and dermato-
scopic information, there is risk of overdiagnosis of actinic keratosis, however.
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Introduction
Facial skin has a particular histologic architecture that differs
from skin on other body sites. Pigmented facial lesions are usu-
ally examined with the unaided eye and with dermatoscopy.1,2
The diagnosis is often challenging because lesions with different
biology (melanoma in situ, actinic keratosis, solar lentigo/sebor-
rhoeic keratosis and basal cell carcinoma) may show similar fea-
tures on dermatoscopy. Facial pigmented lesions often appear
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on a background of severe sun damage,3–7 and collisions8 are
not uncommon. Moreover, biopsies obtained for histopatho-
logic examination may cause scarring and unsatisfactory cos-
metic results. The emerging use of non-invasive therapies creates
a need for non-invasive diagnostic tools that have a higher speci-
ficity than dermatoscopy. Reflectance confocal microscopy
(RCM) is an in vivo diagnostic tool that enables horizontal
imaging of the upper skin layers providing a near cellular resolu-
tion. The method is ideally suited for diagnosis of flat, pig-
mented lesions on the face9–13 with the potential to avoid
unnecessary surgical procedures.
Facial melanoma in situ (lentigo maligna) is a subtype of mel-
anoma that usually presents as a pigmented macule. Diagnostic
features of lentigo maligna (LM) with RCM have been previ-
ously described in detail.9,12,14 Guitera et al.12 developed a diag-
nostic algorithm for LM, comprising two major diagnostic
criteria (non-edged papillae and round large pagetoid cells
>20 lm) and four minor criteria (three or more atypical cells at
the dermo-epidermal junction in five 0.5 9 0.5 mm2 fields,
atypical cells around the follicle, nucleated cells around the folli-
cle and nucleated cells within the dermal papillae) plus one neg-
ative feature (broadened honeycomb pattern). This score
achieved a sensitivity of 93% and specificity of 82% for the diag-
nosis of LM (OR 60.7; 95%; confidence interval: 11.9–309).
RCM features of seborrhoeic keratosis, although not specifically
on the face, have been evaluated in a study by Ahlgrimm-Siess
et al.15 Likewise, features of basal cell carcinoma16,17 and actinic
keratosis18,19 have been previously described.
A retrospective study11 confirmed the RCM features of flat
pigmented lesions of the face and their correlation with der-
matoscopic patterns. RCM features such as atypical cells in the
dermo-epidermal junction (DEJ) and epidermis (mainly den-
dritic cells with adnexal tropism) and a meshwork pattern (cor-
responding to melanocytic nests) at the dermo-epidermal
junction as well as so-called “medusa head-like structures” were
predominantly found in lentigo maligna/lentigo maligna mela-
noma, whereas regular honeycomb and cobblestone pattern and
polycyclic contours were predominantly found in benign lesions.
Although RCM is regarded as an add-on tool of der-
matoscopy, it is controversial how much the additional informa-
tion obtained by RCM impacts the diagnosis and management
of facial lesions in a clinical setting. As many experts of RCM are
also experts in dermatoscopy, it is unclear whether the diagnos-
tic accuracy of RCM depends on the correlation with clinical
and dermatoscopic information or whether RCM, like
histopathology, works as a stand-alone procedure.
Patients & methods
In this prospective study, patients of the outpatient service of the
Department of Dermatology, Medical University of Vienna,
Austria, were included between November 2013 and May 2015.
Eligible participants were individuals over 18 years of age who
presented with flat, pigmented lesions of the face that were
deemed as suspicious by the dermatologist on duty or a referring
dermatologist. Approval of the institutional ethics committee
was obtained (EK-No: 1688/2013), and all participants provided
their written informed consent. The participants were evaluated
in face-to-face (FTF) clinical examination with dermatoscopy by
an expert in dermatoscopy who scheduled patients either for
biopsy/excision or follow-up visits (3 and 9 months after first
visit). Sequential digital dermatoscopy was performed in all
lesions scheduled for follow-up. (MoleMax, Derma Medical Sys-
tems, Vienna, Austria). In those lesions that were biopsied/ex-
cised, histopathologic diagnosis and images were obtained. For
the purpose of documentation, we acquired clinical and der-
matoscopic images of all lesions. We performed RCM in all
lesions. The RCM images were then sent to one of seven expert
confocal readers (randomly selected) who were blinded to the
clinical and dermatoscopic appearance of the lesion, the clinical
diagnosis and the clinical data of the patients. The details of the
study design are shown in Fig. 1.
The expert dermatoscopist and the confocal readers provided
one main diagnosis and up to two differential diagnoses. They
also rated the suspected level of malignancy on a 5-point VAS
scale (0 = definitive benign, 5 = definitive malignant; actinic
keratosis was considered malignant) and the suspected probabil-
ity of diagnosis of a lentigo maligna on a 5-point VAS scale.
(0 = LM ruled out, 5 = LM without doubt). The confocal read-
ers additionally rated image quality on a 5-point VAS scale
(0 = best possible rating) (Figs. 2-5).
For those lesions that were excised, histopathologic diagnosis
served as reference standard. Lesions that were not excised were
regarded as definitely benign if there was no major change (as
compared to baseline digital dermatoscopic and clinical images)
in the 9-month follow-up period. When lesions were excised
due to change or because they were diagnosed as malignant by
confocal readers, histopathologic diagnosis served as reference
standard.
Image acquisition
In all lesions, RCM imaging with a commercially available con-
focal microscope (Vivascope 1500, MAVIG Gmbh, Munich,
Germany) was performed following a standardized imaging pro-
tocol. At least one mosaic of 5–7 mm2 at the level of the epider-
mis, the dermo-epidermal junction (DEJ) and papillary dermis,
respectively, was obtained (approximate depth from the skin
surface: 20 lm, 50 lm and 70 lm).
Results
We invited 67 patients with 73 lesions to participate in the study.
In three patients, it was impossible to obtain RCM images due
to anatomic site (eyebrow, infraorbital region and nose tip,
respectively). Finally, we included 70 lesions of 65 patients (34
male, 31 female; mean age 68 years; median age 69 years; age
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range 36–93 years). Of the 70 lesions, 35 (50.0%) were on the
cheek, 12 (17.1%) were on the forehead, 10 (14.3%) were on the
nose, six (8.6%) were on the temple, two (2.9%) were on the
chin, ear and preauricular area, respectively, and one (1.4%) was
on the upper lip.
Considering only the main diagnosis of the FTF dermato-
scopist, a sensitivity of 73.7% (95% CI 48.80% to 90.85%) and a
specificity of 98.1% (95% CI 89.74% to 99.95%) were achieved.
Considering the main and first differential diagnosis (thus taking
into account lesions that were suspected as benign but excised or
biopsied because malignancy could not be ruled out), the sensi-
tivity of dermatoscopy was 85.0% (95% CI 62.11% to 96.79%)
and the specificity was 84.0% (95% CI 70.89% to 92.83%). The
sensitivity of dermatoscopy plus digital dermatoscopic
Follow-up (FU)
n = 42
• n = 45 minus 3 
excisions due to 
patient wish
Excision/biopsy 
at first visit
n = 28
• 25 due to suspicion of 
malignancy
• 3 due to patient wish
Excision
at second visit
n = 2 
(LM: 2)
Change in
FU
n = 2 
(both LM in RCM)
RCM diagnosis:
LM Excision
n = 3 
(LM: 1; Sol L: 2 (plus 2 LM in 
RCM that were excised due 
to change in FU))
RCM diagnosis:
no LM
further FU
n = 37
FU 3 months:
No change
n = 40
FU 9 months:
No change
n = 37
Histopathology:
benign
n = 11
Histopathology:
malignant
n = 17
(LM: 13; AK: 3; BCC: 1)
FTF visit with dermatoscopy +
management decision
n = 70
Figure 1 Flow Chart of Study Design.
Figure 2 Typical appearance of seborrhoeic keratosis on the
face. (a,b) Clinical and dermatoscopic image of the lesion. (c) RCM
image (1.5 9 1.5 mm) with epidermal projections and typical hon-
eycomb pattern as well as cobblestone pattern. (d) RCM image
(2.5 9 2.5 mm) at DEJ with polycyclic papillae and bulbous pro-
jections. Note density of pilosebaceous units.
Figure 3 Lentigo maligna on the cheek. (a,b) Clinical and der-
matoscopic image. (c) RCM image (0.5 9 0.5 mm) shows disarray
of the epidermis with bright nucleated cells and dendritic cells. (d)
RCM image (0.5 9 0.5 mm) at epidermis/DEJ level reveals nucle-
ated cells and folliculotropism with atypical cells around the
follicle.
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monitoring was 95.0% (95% CI 75.13% to 99.87%), and the
specificity was 84.0% (95% CI 70.89% to 92.83%). For RCM,
the sensitivity was 95.0% (95% CI 75.13% to 99.87%) and
the specificity was 82.0% (95% CI 68.56% to 91.42%),
which remained unchanged when differential diagnoses were
considered.
A combined approach where every lesion was biopsied that
was deemed suspicious either in dermatoscopy or in RCM (as it
was performed in this study setting) achieved a sensitivity of
100.0% (95% CI 83.16% to 100.00%) and a specificity of 74.0%
(95% CI 59.66% to 85.37%) in this study population.
In our study set, there were 15 histopathologically confirmed
lentigo maligna (LM) and one invasive melanoma. Of these 16
melanomas, nine were diagnosed correctly both by the FTF der-
matologist and confocal reader. Two LM that were assigned to
biopsy by the FTF dermatoscopist were diagnosed as solar len-
tigo by RCM, but the differential diagnoses included LM (see
also Tables 1 and 2).
Regarding management decision at the baseline visit, manage-
ment procedure (excision/biopsy vs follow-up) recommended
by FTF dermatologist and confocal reader was the same in 57
lesions, whereas it differed in 13 lesions. Four lesions that were
biopsied or excised at baseline by the FTF dermatologist were
identified correctly as benign by RCM. Three lesions that were
identified correctly as LM in RCM were assigned to follow-up by
the FTF dermatologist. Of those, two lesions showed change in
3-month follow-up visit, and one did not. All three lesions were
excised at 3-month follow-up visit (two due to change plus sus-
picion of LM in RCM plus one due to suspicion of LM in
RCM). One AK in histopathology was correctly identified by
FTF dermatologist but diagnosed as LPLK by confocal reader
and thus would not have been biopsied/excised, leading to one
false-negative result by RCM, although no LM was missed. Two
lesions that were diagnosed as solar lentigo by histopathology
and FTF diagnosis were suspected as LM in RCM (see Fig. 1).
Discussion
Facial melanoma in situ (lentigo maligna) is often diagnosed
when it reached a considerable size spreading to areas where cos-
metic considerations play an important role and functionality
may be impaired by surgery. Furthermore, there is a risk of pro-
gression to invasive melanoma if left untreated.20 Facial skin
Figure 4 Lentigo maligna on the cheek. (a & b) Due to clinical and
dermatoscopic appearance, this lesion was diagnosed as solar
lentigo by FTF dermatologist. (c) RCM image (0.5 9 0.5 mm) at
the epidermal level displays disarray of the epidermis with pagetoid
cells. (d) RCM image (0.5 9 0.5 mm) at epidermis/DEJ reveals
atypical cells.
Figure 5 Histopathologically conﬁrmed solar lentigo on the tem-
ple. (a & b) Clinical and dermatoscopic picture of the lesion that
was assigned to follow-up by FTF dermatologist. (c & d) The RCM
images (0.5 9 0.5 mm) showed epidermal disarray and small
bright nucleated cells leading to the suspicion of LM in confocal;
therefore, a shave biopsy was performed.
Table 1 Correlation between face-to-face diagnosis and ﬁnal diagnosis
FTF
Diagnosis
No. of
lesions
Benign
(Histology
or Follow-up)
LM/MM
(Histology)
BCC
(Histology)
AK
(Histology)
Malignant 25 8
LM/MM 21* 7 13 0 1
BCC 1 0 0 1 0
AK 3 1 0 0 2
Benign 45 42 3† 0 0
37 (FUnc)
5 (H)*
Total 70 50 16 1 3
*Three excised due to patient wish, two excised due to suspicion of malignancy in RCM
†All three suspicions of malignancy in RCM, of those two showed change in 3-month FU. FTF, face to face; LM, lentigo maligna; BCC, basal cell carcinoma;
AK, actinic keratosis; FUnc, no change in follow-up.
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tends to be thinner than skin on other body areas, making it ide-
ally suited for RCM, which provides a resolution comparable to
conventional histology but has a limited imaging depth to
approximately 150 lm from skin surface. Therefore, this investi-
gation exclusively focuses on flat facial lesions
In the prospective design of the study, we aimed to test the
additional value of RCM in a ‘real-life’ setting including patients
referred by either the dermatologist on duty or referring derma-
tologists in private practice. Therefore, we had a high number of
benign lesions in our test set. Among our case series were 15
histopathologically confirmed LM and one invasive melanoma.
Of those, 14 lesions were identified by dermatoscopy or der-
matoscopy follow-up which gave a sensitivity of 95.0%, whereas
one lesion could be identified only by RCM. Five lesions showed
features of actinic keratosis in RCM, but none of these five
showed clinical signs of AK or, if biopsied, were histopathologi-
cally diagnosed as AK. This might be due to the fact that the
facial skin is more exposed to UV light and therefore shows
more subclinical signs of actinic damage compared to other
body sites.
The results underline that RCM is a valid non-invasive
method to detect LM. The main indication includes suspicious
lesions selected by an experienced dermatologist/dermatoscopist.
Even though the time needed for RCM examination of single
lesions might be reduced using a handheld tool, it is still a time-
consuming procedure. It might not be suitable for routine diag-
nosis of numerous lesions, but should be applied to lesions of
special interest following dermatoscopy. Digital dermatoscopic
monitoring is a valid alternative if RCM is not available for flat
facial lesions. A study by Altamura et al.21 showed that in sev-
enty-five per cent of lentigo maligna melanomas, change can be
detected by short-term sequential digital dermatoscopic imaging
within three months. However, benign lesions, especially lichen
planus-like keratosis, may change too. Facial lentigo maligna
usually grows slowly,22 and delay of diagnosis carries a lower risk
than in melanocytic lesions on other body sites. Besides diagno-
sis, it has been shown by others that RCM is also valid for the
presurgical mapping/guidance of biopsy side selection of larger
lesions and for the monitoring of treatment response of non-
surgical treatment. This, however, was not the focus of this
investigation.23
We showed that most flat pigmented facial lesions can be
managed by clinical examination and dermatoscopy (plus digital
dermatoscopic follow-up) alone but we also confirm that RCM
is a useful adjunct in selected lesions.
The specificity of confocal microscopy slightly decreases if it
is not correlated with clinical and dermatoscopic information.
However, in clinical setting, it is routinely used as an adjunct
to clinical and dermatoscopic examination and it has been
demonstrated as an useful tool to increase diagnostic accuracy
in prospective studies.24,25 Furthermore, the current study has
an impact on clinical procedures. Optimally, the clinician who
examines suspicious flat pigmented lesions should be an expert
in dermatoscopy and RCM. The isolated examination of RCM
images bears the risk of inaccurate diagnosis. This is quite dif-
ferent from histopathology where in many lesions, the
histopathologist does not have clinical information or images.
The results of our study indicate that for RCM, a clinic-patho-
logic correlation is important and should ideally be made at
the patient visit.
The need of full contact between the RCM device and the
skin is challenging on the face due to the convex and concave
areas and led to exclusion of some lesions for this study
which has been performed with a conventional confocal
microscope rather than with a smaller handheld device that is
commercially available (Vivascope 3000). This handheld
device has been shown to be useful on curvy anatomical sites,
(especially as these sites are often the ones where operation
might render more difficulty).26–29 The possibility of obtain-
ing a larger area of view with the handheld confocal micro-
scope may facilitate its usability.30
Like any clinical tool, training is required for effective use and
diagnostic accuracy of both methods is dependent on evaluator
experience. We think that the preference of use of RCM or der-
matoscopy should depend on training and local resources.
The results of the study presented herein add to the larger
scale validation that is needed for more widespread adoption of
this technology.
Table 2 Correlation between RCM diagnosis and ﬁnal diagnosis.
RCM
Diagnosis
No. of
lesions
Benign
(Histology or
Follow-up)
LM/MM
(Histology)
BCC
(Histology)
AK (Histology)
Malignant 28 9
LM/MM 20 4 16 0 0
BCC 1 0 0 1 0
AK 7 5 0 0 2
Benign 42 41 0 0 1
35 (FUnc)
6 (H)
Total 70 50 16 1 3
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In conclusion, RCM is a valid diagnostic method for flat pig-
mented lesions on the face, complementary to dermatoscopic
evaluation. RCM diagnosis alone, without clinical and dermato-
scopic information, might lead to overdiagnosis of actinic ker-
atosis and even lentigo maligna, however.
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